Cite
Philadelphia chromosome-negative myeloproliferative chronic neoplasms: is clonal hematopoiesis the main determinant of autoimmune and cardio-vascular manifestations?
MLA
Giovanni Fulvio, et al. “Philadelphia Chromosome-Negative Myeloproliferative Chronic Neoplasms: Is Clonal Hematopoiesis the Main Determinant of Autoimmune and Cardio-Vascular Manifestations?” Frontiers in Medicine, vol. 10, Oct. 2023. EBSCOhost, https://doi.org/10.3389/fmed.2023.1254868.
APA
Giovanni Fulvio, Chiara Baldini, Marta Mosca, Antonello di Paolo, Guido Bocci, Giuseppe Alberto Palumbo, Emma Cacciola, Paola Migliorini, Rossella Cacciola, & Sara Galimberti. (2023). Philadelphia chromosome-negative myeloproliferative chronic neoplasms: is clonal hematopoiesis the main determinant of autoimmune and cardio-vascular manifestations? Frontiers in Medicine, 10. https://doi.org/10.3389/fmed.2023.1254868
Chicago
Giovanni Fulvio, Chiara Baldini, Marta Mosca, Antonello di Paolo, Guido Bocci, Giuseppe Alberto Palumbo, Emma Cacciola, Paola Migliorini, Rossella Cacciola, and Sara Galimberti. 2023. “Philadelphia Chromosome-Negative Myeloproliferative Chronic Neoplasms: Is Clonal Hematopoiesis the Main Determinant of Autoimmune and Cardio-Vascular Manifestations?” Frontiers in Medicine 10 (October). doi:10.3389/fmed.2023.1254868.